<DOC>
	<DOCNO>NCT01874613</DOCNO>
	<brief_summary>Bioactive fibre-reinforced composite implant use reconstruction skull bone defect orbital floor defect . Functional aesthetic outcome assess patient doctor .</brief_summary>
	<brief_title>Clinical Study FRC Implant Treat Skull Bone Defects</brief_title>
	<detailed_description>Development phase : Clinical trial Objectives : Assessment functional aesthetic outcome Methodology : Intervention study Sample size : 35+20+25 Main criterion inclusion : Skull bone defect OR orbital floor fracture Investigational drug/treatment , dose mode administration : FRC implant Comparative drug ( ) /placebo/treatment , dose mode administration : - Duration treatment : 2 year follow-up Assessments : Clinical outcome radiologic assesment Functional aesthetic outcome Visual Analog Scale ( VAS ) . Pain assessment VAS . Statistical method : Adequate statistical method publish international peer-reviewed journal .</detailed_description>
	<criteria>Study arm 1 : patient skull bone defect reconstruction indication fullfilled Study arm 2 : patient orbital floor defect reconstruction indication fullfilled informed consent obtain</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Craniofacial bone reconstruction</keyword>
	<keyword>Fibre-reinforced composite</keyword>
	<keyword>Bioactive glass</keyword>
	<keyword>Craniotomy</keyword>
	<keyword>Skull bone defect</keyword>
</DOC>